|
|
|
|
|
|
|
|
Wednesday, March 9
|
|
|
|
|
|
|
|
|
|
|
6:00pm-8:00 pm
|
Registration
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thursday Morning, March 10
|
|
|
|
|
|
|
|
|
|
|
7:00am-7:30pm
|
Registration
|
|
|
|
|
|
|
|
|
|
8:45am-4:45pm
|
WORKSHOPS
|
|
|
|
|
|
(open to all participants - applicable to physicians, nurses and allied personnel) (Codes: C= Core workshop, I = Intermediate, A = Advanced, N= Nurses, AP = of interest to nurses and allied personnel)
Workshops designated by an asterisk (*) will be presented twice in different time slots.
Workshops presented in a series are marked with a "1" for a primary workshop discussion in this area and "2" for a more complex or advanced discussion in this area.
Please note that the series workshops 1 and 2 can be either taken subsequently (following each other) or they can each be taken independently (e.g. workshop 1 can be taken without taking workshop 2 and vice versa).
|
|
|
|
WORKSHOP GROUP 1
|
8:45-10:15
|
|
|
|
|
|
|
|
8:45-10:15
|
A01 CRRT Systems I
I. Fresenius Systems
|
|
|
Christian Schlaeper, MS
|
|
|
|
|
|
|
8:45-10:15
|
A01 II. Baxter - Edwards Lifesciences Critical Care Nephrology Alliance Accura/Aquarius
|
|
|
Bev Ryan, RN Lee C. Ware, RN
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
8:45-10:15
|
B02 Vascular Access /Membrane and Circuit 1
|
|
|
Ian Baldwin, RN, MN, ACCCN Reinhold Deppisch, PhD Michael A. Kraus, MD
|
|
|
Principles of catheter choice, placement, maintenance, recognition and management of complications, selection and use of membranes for different applications, circuit design, setup and monitoring
|
|
|
|
8:45-10:15
|
C03 Dialysis Dose Prescription and Delivery 1
|
|
|
William R. Clark, MD Mark R. Marshall, MD, FRACP Claudio Ronco, MD
|
|
|
Operational characteristics influencing solute removal in IHD, PD and CRRT
|
|
|
|
8:45-10:15
|
D04 Drug Management 1
|
|
|
Thomas A. Golper, MD Bruce A. Mueller, PharmD, FCCP Miet Schetz, MD, PhD
|
|
|
Dosing principles for critically ill patients and adjustments in extracorporeal support techniques
|
|
|
|
8:45-10:15
|
E05 CRRT Around the World: Clinical Vignettes
|
|
|
Emmanuel Burdmann, MD, PhD Rajasekara Chakravarthi, MD, DNB (Nephrology) Lei-shi Li, MD, FHKCP Fernando Liaño, MD, PhD Patrick T. Murray, MD
|
|
|
Illustrative cases demonstrating applications of CRRT in various settings. Application of CRRT in developing countries
|
|
|
|
8:45-10:15
|
F06 Extracorporeal Techniques for Sepsis 1
|
|
|
Patrick M. Honoré, MD Stanislao Morgera, MD Ramesh Venkataraman, MD
|
|
|
Rationale for use of extracorporeal support in treatment of sepsis. Experimental models for high permeability membranes, HVHF, VHVHF and hybrid therapies
|
|
|
|
8:45-10:15
|
G07 Advances in Technology
Moderator: Ravindra Mehta, MD
1. Baxter/Edwards Critical Care Alliance
2. B. Braun Medical, Inc.
3. DSI-Dialysis Solutions, Inc.
4. Fresenius Medical Care
5. Gambro
6. Nephros Therapeutics
7. NxStage Medical, Inc.
|
|
|
|
|
|
This workshop highlights the current and future advances in technology for extracorporeal support. Available equipment and products from different providers will be compared. This workshop provides a glimpse of all the key equipment and products available for CRRT in one session
|
|
|
|
10:15-10:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
WORKSHOP GROUP 2
|
10:30-12:00
|
|
|
|
|
|
|
|
10:30-12:00
|
A08 CRRT Systems II
I. Nephros Therapeutics
|
|
|
Nancy Bullard, RN, CNN Rick DaSilva, RN
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
10:30-12:00
|
A08 CRRT Systems II
II. NxStage Therapy System
|
|
|
Susan Dirkes, RN, MSA, CCRN
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
10:30-12:00
|
B09 Anticoagulation 1: Mechanisms and Techniques
|
|
|
Andrew Davenport, MD, MA Ashita Tolwani, MD
|
|
|
Anticoagulation regimens: Mechanisms, selection, prescription, monitoring and implementation
|
|
|
|
10:30-12:00
|
C10 Fluid Management 1
|
|
|
Ravindra L. Mehta, MBBS, MD, FACP Michael R. Pinsky, MD
|
|
|
Principles of volume assessment, fluid removal and fluid regulation with different CRRT equipment
|
|
|
|
10:30-12:00
|
D11 Developing, Implementing and Maintaining a CRRT Program
|
|
|
Jorge Cerda, MD, FACP, FASN Rhonda K. Martin, RN, MS, MLT(ASCP) Karen Schardin, RN
|
|
|
Practical issues for organization and implementation of a CRRT program. Developing and implementing policies and protocols for CRRT
|
|
|
|
10:30-12:00
|
E12 Plasma Exchange Therapy and Hybrid Techniques 1
|
|
|
H. David Humes, MD Andre A. Kaplan, MD Shigeto Oda, MD
|
|
|
Principles of plasma exchange, sorbent based and hybrid therapies for extracorporeal support. Results from experimental models and human studies
|
|
|
|
10:30-12:00
|
F13 Heart Failure and Cardio-Renal Syndrome 1
|
|
|
Richard Amerling, MD Alan Maisel, MD Emil P. Paganini, MD, FACP, FRCP James A. Tumlin, MD
|
|
|
Pathophysiology, recognition and management strategies for cardiac and renal failure in the critically ill patient
|
|
|
|
10:30-12:00
|
G14 Pediatric CRRT: The Basics
|
|
|
Steven R. Alexander, MD Patrick D. Brophy, MD, FAAP, FRCPC Timothy E. Bunchman, MD Stuart L. Goldstein, MD Jordan M. Symons, MD
|
|
|
Technique requirement and application for use in children including neonates
|
|
|
|
12:00-1:30
|
Lunch on your own
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thursday Afternoon, March 10
|
|
|
|
|
|
|
|
|
|
|
WORKSHOP GROUP 3
|
1:30-3:00
|
|
|
|
|
|
|
|
1:30-3:00
|
A15 CRRT Systems III
I. Gambro Prisma
|
|
|
Stacey L. Johnson
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
1:30-3:00
|
A15 CRRT Systems III
II. B.Braun Diapact
|
|
|
Tony Annone, CRRT Product Special Ken Click, CRRT Product Special
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
1:30-3:00
|
B16 Solutions for CRRT 1
|
|
|
Timothy E. Bunchman, MD Michael A. Kraus, MD Emil P. Paganini, MD, FACP, FRCP Amy M. Sprague, MD Sheldon W. Tobe, MD
|
|
|
Basic concepts for formulation and application of various solutions for pre-dilution, replacement and dialysate in critically ill patients
|
|
|
|
1:30-3:00
|
C17 Therapy Comparisons I: SLED vs. CRRT vs. PD
|
|
|
Richard Amerling, MD Ian Baldwin, RN, MN, ACCCN Mark R. Marshall, MD, FRACP Raymond C. Vanholder, MD PhD
|
|
|
Comparisons of operational characteristics including anticoagulation, membranes, solutions and flows and approaches for ongoing and future research
|
|
|
|
1:30-3:00
|
D18 Nutritional Assessment and Support 1
|
|
|
Paul E. Marik, MD Miguel C. Riella, MD, PhD
|
|
|
Pathophysiology of malnutrition in critically ill patients. Principles of nutritional assessment and support
|
|
|
|
1:30-3:00
|
E19 A Systems-based Approach to CRRT
|
|
|
Geraldine Biddle, RN, CNN, CPHQ Ravindra L. Mehta, MBBS, MD, FACP
|
|
|
Principles of systems based management strategies and their application to CRRT. Approaches to reduce errors in therapy prescription and delivery
|
|
|
|
1:30-3:00
|
F20 Hepatic Failure and Hepato-renal Syndrome 1
|
|
|
Tarek Hassanein, MD Kang H. Lee, MD Jan Stange, MD
|
|
|
Pathophysiology of hepatic failure and rationale for use of different techniques for extracorporeal support techniques (Cell based systems, MARS, CRRT) for hepatic support
|
|
|
|
1:30-3:00
|
G21 Nursing Issues in Pediatric CRRT
|
|
|
Helen Currier, BSN, RN, CNN John Gardner, RN
|
|
|
Practical issues for setting up and maintaining a pediatric CRRT program. Policies and procedures and protocol based management
|
|
|
|
3:00-3:15
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
WORKSHOP GROUP 4
|
3:15-4:45
|
|
|
|
|
|
|
|
3:15-4:45
|
A22 CRRT Systems I
I. Fresenius Systems
|
|
|
Christian Schlaeper, MS
|
|
|
|
|
|
|
3:15-4:45
|
A22 II. Baxter - Edwards Lifesciences Critical Care Nephrology Alliance Accura/Aquarius
|
|
|
Bev Ryan, RN Lee C. Ware, RN
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
3:15-4:45
|
B23 Vascular Access/Membrane and Circuit 2
|
|
|
Ian Baldwin, RN, MN, ACCCN Reinhold Deppisch, PhD Michael A. Kraus, MD
|
|
|
Case based discussion of various factors influencing circuit longevity, membrane function and troubleshooting for problems encountered
|
|
|
|
3:15-4:45
|
C24 Dialysis Dose Prescription and Delivery 2
|
|
|
William R. Clark, MD Mark R. Marshall, MD, FRACP Claudio Ronco, MD
|
|
|
Case based discussions of prescription of dose, modality choice and optimal dose delivery to match the therapy to the patients need
|
|
|
|
3:15-4:45
|
D25 Drug Management 2
|
|
|
Thomas A. Golper, MD Bruce A. Mueller, PharmD, FCCP Miet Schetz, MD, PhD
|
|
|
Case based discussion of practical aspects for drug prescription, delivery and management of drug interactions in CRRT
|
|
|
|
3:15-4:45
|
E26 CRRT Around the World
|
|
|
Emmanuel Burdmann, MD, PhD Rajasekara Chakravarthi, MD, DNB (Nephrology) Lei-shi Li, MD, FHKCP Fernando Liaño, MD, PhD Patrick T. Murray, MD
|
|
|
Illustrative cases demonstrating applications of CRRT in various settings. Application of CRRT in developing countries
|
|
|
|
3:15-4:45
|
F27 Extracorporeal Techniques for Sepsis 2
|
|
|
Patrick M. Honoré, MD Stanislao Morgera, MD Ramesh Venkataraman, MD
|
|
|
Technical considerations and practical application of extracorporeal support techniques for sepsis. Results of human studies for use of high permeability membranes, HVHF, VHVHF and hybrid techniques for sepsis
|
|
|
|
3:15-4:45
|
G28 Advances in Technology
Moderator: Ravindra Mehta, MD
1. Baxter/Edwards Critical Care Alliance
2. B. Braun Medical, Inc.
3. DSI-Dialysis Solutions, Inc.
4. Fresenius Medical Care
5. Gambro
6. Nephros Therapeutics
7. NxStage Medical, Inc.
|
|
|
|
|
|
This workshop highlights the current and future advances in technology for extra corporeal support. Available equipment and components from different providers will be compared. This workshop provides a glimpse of all the key equipment and products available for CRRT in one session
|
|
|
|
4:45
|
Adjourn
|
|
|
|
|
|
|
|
|
|
5:00-6:30
|
Opening Ceremony - A Historical Perspective of CRRT
An overview of the technology and how the therapeutic machinery has evolved; and a viewpoint of how the technology may be changing in the next few years.
Moderator: Thomas Golper, MD
|
|
|
Thomas A. Golper, MD Lee Henderson, MD Claudio Ronco, MD
|
|
|
5:15-5:45 pm
The Beginning of Hemofiltration
Lee Henderson, MD
5:45-6:00 pm
Technological Advances in Continuous Therapies:
The Past, the Present and the Future
Claudio Ronco, MD
|
|
|
|
6:30-8:00
|
Welcome Reception
Poster Viewing and Exhibits Open
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Friday Morning, March 11
|
|
|
|
|
|
|
|
|
|
|
6:30am-6:00pm
|
Registration
|
|
|
|
|
|
|
|
|
|
|
Session I: Patient Characteristics
|
|
|
|
|
|
|
|
|
|
7:20-7:30
|
Opening Remarks
|
|
|
Ravindra L. Mehta, MBBS, MD, FACP
|
|
|
|
|
|
|
MINI-SYMPOSIA
Organ Dysfunction in the Critically Ill Patient: Emerging Concepts
|
7:30-9:45
|
Co-chair: William L. Macias, MD, PhD Co-chair: Michael R. Pinsky, MD
|
|
|
|
|
|
|
7:30- 7:50
|
Acute Kidney Injury: Mechanisms and Adaptations
|
|
|
Joseph V. Bonventre, MD, PhD
|
|
|
|
|
|
|
7:50- 8:10
|
Stress Hyperglycemia, Insulin and Immunomodulation in Sepsis
|
|
|
Paul E. Marik, MD
|
|
|
|
|
|
|
8:10-8:30
|
Hepatic Failure and Hepatorenal Syndrome
|
|
|
Kang H. Lee, MD
|
|
|
|
|
|
|
8:30-8:50
|
Brain Injury
|
|
|
Hoi Sang U, MD
|
|
|
|
|
|
|
8:50-9:10
|
Pathophysiology of Uremia
|
|
|
Raymond C. Vanholder, MD PhD
|
|
|
|
|
|
|
9:10-9:30
|
Repair Mechanisms: The Role of Stem Cells
|
|
|
Joseph V. Bonventre, MD, PhD
|
|
|
|
|
|
|
9:30-9:45
|
Panel Discussion
Moderator: Noel Gibney, MD
|
|
|
Noel Gibney, MD
|
|
|
|
|
|
|
9:45-10:00
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
MINI-SYMPOSIA
Controversies in Management of the Critically Ill Patient: Can We Modulate
|
10:00-12:30
|
Co-chair: Lee Henderson, MD Co-chair: Miet Schetz, MD, PhD
|
|
|
|
|
|
|
10:00-10:20
|
Dysregulation of the Immune Response in Sepsis: Opportunities to Intervene?
|
|
|
Michael R. Pinsky, MD
|
|
|
|
|
|
|
10:20-10:35
|
Re-establishing Organ Function in Severe Sepsis: Targeting the Microcirculation
|
|
|
William L. Macias, MD, PhD
|
|
|
|
|
|
|
10:35-10:55
|
Immunomodulation with High Volume Hemofiltration
|
|
|
Patrick M. Honoré, MD
|
|
|
|
|
|
|
10:55-11:15
|
Hemofiltration: Effect on Apoptosis
|
|
|
Claudio Ronco, MD
|
|
|
|
|
|
|
11:15-11:35
|
High Permeability Membrane Hemofiltration and Dialysis: Effects on Inflammatory Mediators
|
|
|
Stanislao Morgera, MD
|
|
|
|
|
|
|
11:35-11:55
|
Immunomodulation With Cell-based Systems
|
|
|
James A. Tumlin, MD
|
|
|
|
|
|
|
11:55-12:15
|
Cytokine Removal with Sorbents
|
|
|
Ramesh Venkataraman, MD
|
|
|
|
|
|
|
12:15-12:30
|
Panel Discussion
Moderator: Emil Paganini, MD
|
|
|
Emil P. Paganini, MD, FACP, FRCP
|
|
|
|
|
|
|
12:30-1:30
|
Lunch Hosted by Conference
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Friday Afternoon, March 11
|
|
|
|
|
|
|
|
|
|
|
|
Session II: Emerging Concepts in ARF and CRRT
|
|
|
|
|
|
|
|
|
|
1:30-3:00
|
Concurrent Workshops and Nursing and Allied Personnel Sessions
|
|
|
|
|
|
|
|
|
|
|
Simultaneous Session for Nursing and Allied Personnel
|
|
|
|
|
|
|
|
|
|
MINI-SYMPOSIA
Contemporary Topics in Nursing Care: Interdisciplinary Interactions
|
1:30-3:00
|
Co-chair: Geraldine Biddle, RN, CNN, CPHQ Co-chair: Helen Currier, BSN, RN, CNN
|
|
|
|
|
|
|
1:30-1:50
|
Improving Patient Safety: Preventing Errors
|
|
|
Bruce A. Mueller, PharmD, FCCP
|
|
|
|
|
|
|
1:50-2:10
|
Training and Retaining Nurses in the ICU: The ECCO Approach
|
|
|
Deborah Ann Snyder, RN, MSN, CCRN
|
|
|
|
|
|
|
2:10-2:30
|
Nursing Standards and Competency Assessment for Extracorporeal Techniques
|
|
|
Ian Baldwin, RN, MN, ACCCN
|
|
|
|
|
|
|
2:30-2:50
|
The Future of Nephrology Nursing Practice: Is the ICU Off Limits?
|
|
|
Rhonda K. Martin, RN, MS, MLT(ASCP)
|
|
|
|
|
|
|
2:50-3:00
|
Panel Discussion
Moderator: Patti Graham, RN
|
|
|
Patti Graham, RN
|
|
|
|
|
|
|
WORKSHOP GROUP 5
|
1:30-3:00
|
|
|
|
|
|
|
|
1:30-3:00
|
A29 CRRT Systems II
I. Nephros Therapeutics
|
|
|
Nancy Bullard, RN, CNN Rick DaSilva, RN
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
1:30-3:00
|
A29 CRRT Systems II
II. NxStage Therapy System
|
|
|
Susan Dirkes, RN, MSA, CCRN
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
1:30-3:00
|
B30 Anticoagulation 2: Special Techniques Citrate
|
|
|
Timothy E. Bunchman, MD Andrew Davenport, MD, MA Noel Gibney, MD Thomas A. Golper, MD Ashita Tolwani, MD David M. Ward, MD, FRCP
|
|
|
Comparison of various techniques for regional citrate anticoagulation including requirements, setup, monitoring and results
|
|
|
|
1:30-3:00
|
C31 Fluid Management 2
|
|
|
Ravindra L. Mehta, MBBS, MD, FACP Michael R. Pinsky, MD
|
|
|
Case based discussion of application of techniques for fluid regulation in CRRT
|
|
|
|
1:30-3:00
|
D32 Developing, Implementing and Maintaining a CRRT Program
|
|
|
Jorge Cerda, MD, FACP, FASN Rhonda K. Martin, RN, MS, MLT(ASCP) Karen Schardin, RN
|
|
|
Practical issues for organization and implementation of a CRRT program. Developing and implementing policies and protocols for CRRT
|
|
|
|
1:30-3:00
|
E33 Plasma Exchange Therapy and Hybrid Techniques 2
|
|
|
H. David Humes, MD Andre A. Kaplan, MD Shigeto Oda, MD
|
|
|
Case based discussion of practical application of plasma exchange, sorbent based and hybrid therapies for extracorporeal support.
|
|
|
|
1:30-3:00
|
F34 Heart Failure and Cardio-renal Syndrome 2
|
|
|
Richard Amerling, MD Alan Maisel, MD Emil P. Paganini, MD, FACP, FRCP James A. Tumlin, MD
|
|
|
Technical considerations, practical application and results of different methods to treat heart failure and cardio-renal syndrome
|
|
|
|
1:30-3:00
|
G35 Non-renal Indications for Pediatric CRRT
|
|
|
Patrick D. Brophy, MD, FAAP, FRCPC Joseph V. DiCarlo, MD Stuart L. Goldstein, MD Kevin McBryde, MD
|
|
|
Case based discussion of non-renal indications for CRRT in pediatric patients including inborn errors of metabolism and poisonings
|
|
|
|
3:00-3:15
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
MINI-SYMPOSIA
Surviving Acute Renal Failure in the ICU: Strategies for Success?
|
3:15-5:30
|
Co-chair: Patrick M. Honoré, MD Co-chair: Mark D. Okusa, MD
|
|
|
|
|
|
|
3:15-3:30
|
Ischemic Acute Renal Failure: An Inflammatory Disease?
|
|
|
Hamid Rabb, MD, FACP
|
|
|
|
|
|
|
3:30-3:45
|
Predicting Outcomes in Critically Ill Patients: Which Markers?
|
|
|
Miet Schetz, MD, PhD
|
|
|
|
|
|
|
3:45-4:00
|
Long-term Outcomes From ARF
|
|
|
Fernando Liaño, MD, PhD
|
|
|
|
|
|
|
4:00-4:15
|
Sepsis and ARF: Prevalence and Consequences
|
|
|
Raymond C. Vanholder, MD PhD
|
|
|
|
|
|
|
4:15-4:30
|
Organ Cross-Talk: Combined Lung & Renal Injury
|
|
|
Hamid Rabb, MD, FACP
|
|
|
|
|
|
|
4:30-4:45
|
Timing is Everything: The Case for Early Intervention
|
|
|
Ravindra L. Mehta, MBBS, MD, FACP
|
|
|
|
|
|
|
4:45-5:00
|
Interventions in ARF - What Has Been Tried?
|
|
|
Patrick T. Murray, MD
|
|
|
|
|
|
|
5:00-5:30
|
Panel Discussion
Moderator: Miguel Riella, MD PhD
|
|
|
Miguel C. Riella, MD, PhD
|
|
|
|
|
|
|
5:30
|
Adjourn
|
|
|
|
|
|
|
|
|
|
6:30-10:00
|
Social Event on the Midway, San Diego Aircraft Carrier Museum
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Saturday Morning, March 12
|
|
|
|
|
|
|
|
|
|
|
7:00am-5:00pm
|
Registration
|
|
|
|
|
|
|
|
|
|
|
Session III: Technique Characteristics
|
|
|
|
|
|
|
|
|
|
MINI-SYMPOSIA
Challenges and Controversies in CRRT
|
7:45-10:15
|
Co-chair: Lei-shi Li, MD, FHKCP
|
|
|
|
|
|
|
7:45-8:05
|
Hemodynamic Instability During Different Forms of Dialysis Therapy: Do We Really Know Why?
|
|
|
Lee Henderson, MD
|
|
|
|
|
|
|
8:05-8:20
|
Anticoagulation in CRRT: Is Citrate the Anticoagulant of Choice?
|
|
|
Andrew Davenport, MD, MA
|
|
|
|
|
|
|
8:20-8:35
|
Bloodstream Infections: Does the Vascular Access Contribute?
|
|
|
Reinhold Deppisch, PhD
|
|
|
|
|
|
|
8:35-8:50
|
Nutritional Support in the Critically Ill Patient: How Much is Enough?
|
|
|
Paul E. Marik, MD
|
|
|
|
|
|
|
8:50-9:05
|
Bicarbonate-based Fluids for CRRT: The New Standard?
|
|
|
Michael A. Kraus, MD
|
|
|
|
|
|
|
9:05-9:20
|
Fluid Balance in CRRT: A predictor of Outcome?
|
|
|
Timothy E. Bunchman, MD
|
|
|
|
|
|
|
9:20-9:50
|
Debate: SLED is an Effective and More Desirable Therapy Than CRRT for Renal Replacement in the ICU
|
|
|
Mark R. Marshall, MD, FRACP Emil P. Paganini, MD, FACP, FRCP
|
|
|
|
|
|
|
9:50-10:15
|
Panel Discussion
Thomas Golper, MD
|
|
|
Thomas A. Golper, MD
|
|
|
|
|
|
|
10:15-10:30
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
SPECIAL SESSION
Applications for RRT: What's New?
|
10:30-12:30
|
Co-chair: Steven R. Alexander, MD Co-chair: Ashita Tolwani, MD
|
|
|
|
|
|
|
10:30-10:50
|
Coupled Plasma-Filtration Adsorption
|
|
|
Claudio Ronco, MD
|
|
|
|
|
|
|
10:50-11:10
|
CRRT for Acute Respiratory Failure Following Bone Marrow Transplant in Pediatric Patients
|
|
|
Joseph V. DiCarlo, MD
|
|
|
|
|
|
|
11:10-11:30
|
MARS Treatment for Hepatic Encephalopathy: Results of a Randomized Controlled Trial
|
|
|
Tarek Hassanein, MD
|
|
|
|
|
|
|
11:30-11:50
|
Complications of CRRT: Lessons From Pediatric Patients
|
|
|
Stuart L. Goldstein, MD
|
|
|
|
|
|
|
11:50-12:10
|
Minimizing Complications With Dialysis: Recommendations From the ADQI IV Conference
|
|
|
Andrew Davenport, MD, MA
|
|
|
|
|
|
|
12:10-12:30
|
Panel Discussion
Moderator: William Clark, MD
|
|
|
William R. Clark, MD
|
|
|
|
|
|
|
12:30-1:30
|
Lunch Hosted by Conference
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Saturday Afternoon, March 12
|
|
|
|
|
|
|
|
|
|
|
|
Session IV: Future Trends in CRRT
|
|
|
|
|
|
|
|
|
|
1:30-3:00
|
Concurrent Workshops and Nursing and Allied Personnel Sessions
|
|
|
|
|
|
|
|
|
|
|
Simultaneous Session for Nursing and Allied Personnel
|
|
|
|
|
|
|
|
|
|
MINI SYMPOSIA
The Year in Review: What You Should Know and Care About
|
1:30-3:00
|
Co-chair: Karen Schardin, RN Co-chair: Deborah Ann Snyder, RN, MSN, CCRN
|
|
|
|
|
|
|
1:30-1:50
|
Critical Care Nephrology
|
|
|
Jorge Cerda, MD, FACP, FASN
|
|
|
|
|
|
|
1:50-2:10
|
Nursing
|
|
|
Geraldine Biddle, RN, CNN, CPHQ
|
|
|
|
|
|
|
2:10-2:30
|
Pharmacotherapeutics
|
|
|
Bruce A. Mueller, PharmD, FCCP
|
|
|
|
|
|
|
2:30-2:50
|
Clinical Information Systems
|
|
|
Noel Gibney, MD
|
|
|
|
|
|
|
2:50-3:00
|
Panel Discussion
Moderator: Rhonda Martin, RN
|
|
|
Rhonda K. Martin, RN, MS, MLT(ASCP)
|
|
|
|
|
|
|
WORKSHOP GROUP 6
|
1:30-3:00
|
|
|
|
|
|
|
|
1:30-3:00
|
A36 CRRT Systems III
I. Gambro Prisma
|
|
|
Stacey L. Johnson
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
1:30-3:00
|
A36 CRRT Systems III
II. B.Braun Diapact
|
|
|
Tony Annone, CRRT Product Special Ken Click, CRRT Product Special
|
|
|
Device demonstrations of features, setup, operation, monitoring and discontinuation
|
|
|
|
1:30-3:00
|
B37 Solutions for CRRT 2
|
|
|
Neill Adhikari, MD, CM Linda Awdishu, BSc Pharm Adriana Berbece, MD Timothy E. Bunchman, MD Leasa A Knechtel, RN, BScN, MN, CNCC(c Michael A. Kraus, MD Emil P. Paganini, MD, FACP, FRCP Amy M. Sprague, MD Ashita Tolwani, MD
|
|
|
Case based discussions of applications of solutions for acid-base and metabolic control, electrolyte and divalent ion homeostasis
|
|
|
|
1:30-3:00
|
C38 Therapy Comparisons I: SLED vs. CRRT vs. PD
|
|
|
Richard Amerling, MD Ian Baldwin, RN, MN, ACCCN Mark R. Marshall, MD, FRACP Raymond C. Vanholder, MD PhD
|
|
|
Comparisons of operational characteristics including anticoagulation, membranes, solutions and flows and approaches for ongoing and future research
|
|
|
|
1:30-3:00
|
D39 Nutritional Assessment and Support 2
|
|
|
Paul E. Marik, MD Miguel C. Riella, MD, PhD
|
|
|
Case based discussion of technical and practical considerations for nutritional support with CRRT
|
|
|
|
1:30-3:00
|
E40 A Systems-based Approach to CRRT
|
|
|
Geraldine Biddle, RN, CNN, CPHQ Ravindra L. Mehta, MBBS, MD, FACP
|
|
|
Principles of systems based management strategies and their application to CRRT. Approaches to reduce errors in therapy prescription and delivery
|
|
|
|
1:30-3:00
|
F41 Hepatic Failure and Hepato-renal Syndrome 2
|
|
|
Barbra Alan, RN, CNN Tarek Hassanein, MD Kang H. Lee, MD Jan Stange, MD
|
|
|
Technical considerations, practical application and results of different methods of hepatic support for patients with hepatic failure and hepatorenal syndrome
|
|
|
|
1:30-3:00
|
G42 Controversies in Pediatric CRRT
|
|
|
Steven R. Alexander, MD Patrick D. Brophy, MD, FAAP, FRCPC Stuart L. Goldstein, MD Jordan M. Symons, MD
|
|
|
Pro-con discussions of key areas of controversy in pediatric CRRT including citrate vs heparin; pharmacy-made vs commercial solutions, choice of modality
|
|
|
|
3:00-3:15
|
Coffee Break
|
|
|
|
|
|
|
|
|
|
MINI-SYMPOSIA
Looking to the Future: What Can We Expect?
|
3:15-5:00
|
|
|
|
|
|
|
|
3:15- 3:35
|
Therapeutic Targets and Interventions for ARF
|
|
|
Mark D. Okusa, MD
|
|
|
|
|
|
|
3:35-3:55
|
The Future of CRRT in Developing Countries: Lessons from China
|
|
|
Lei-shi Li, MD, FHKCP
|
|
|
|
|
|
|
3:55- 4:15
|
Enhancements in Technology: What's Needed?
|
|
|
Ian Baldwin, RN, MN, ACCCN
|
|
|
|
|
|
|
4:15- 4:35
|
Communications Standards for CRRT Machines: The ADQI/IEEE Initiative
|
|
|
Todd Cooper
|
|
|
|
|
|
|
4:35-5:00
|
Panel Discussion
Moderator: Andre Kaplan, MD
|
|
|
Andre A. Kaplan, MD
|
|
|
|
|
|
|
5:00
|
Closing Remarks
|
|
|
Ravindra L. Mehta, MBBS, MD, FACP
|
|
|
|
|
|
|
5:05
|
Adjourn
|
|
|
|
|
|
|